Table 2: Incidence of major cardiac and cerebrovascular events after initiation of bevacizumab treatment, difference between patients achieving induction or not.
Condition | N, ≥ 3 injections | N, < 3 injections | p-value | OR | CI |
TIA | 70 | 9 | 0.23 | 0.64 | 0.30 - 1.33 |
CVA | 130 | 28 | 0. 83 | 1.05 | 0.68 - 1.63 |
CHF | 172 | 25 | 0.14 | 0.72 | 0.46 - 1.12 |
MI | 39 | 9 | 0.65 | 1.19 | 0.53 - 2.57 |